Company news
Mayne Pharma Group Ltd. (ASX:MYX) news
Every Mayne Pharma Group Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
2026 Full Year Results Media Release
August 26, 2026
Mayne Pharma reports unaudited Q4 and FY26 results
July 30, 2026
Mayne Pharma receives $14.4m for legal costs from Cosette
June 4, 2026
Court awards MYX $13.27m for legal costs from Cosette
May 21, 2026
Mayne Pharma reports unaudited 3Q FY26 results
April 28, 2026
S&P DJI Announces March 2026 Quarterly Rebalance
March 6, 2026
2026 Half Year Investor Presentation
February 22, 2026
2026 Half Year Media Release
February 22, 2026
Half Yearly Report and Accounts
February 22, 2026
Mayne Pharma Management Changes
February 22, 2026
MYX to claim against Cosette, Avista & Mr David Burgstahler
February 17, 2026
2025 AGM presentation and business update
January 28, 2026
Market Update
December 21, 2025
Termination of Proposed Acquisition of Mayne Pharma
December 11, 2025
Mayne Pharma terminates Scheme Implementation Deed
December 10, 2025
MYX receives purported termination notice from Cosette
December 9, 2025
Mayne Pharma issues notice of intention to terminate the SID
December 3, 2025
Update on FIRB condition and scheme
November 21, 2025
Trading Halt
November 20, 2025
Pause in Trading
November 20, 2025
Update on status of FIRB approval and second court hearing
November 20, 2025
MYX Declaration of Unacceptable Circumstances and Orders
November 19, 2025
Update on FIRB approval and Scheme
November 17, 2025
MYX - Panel Conducts Proceedings and Makes Interim Orders
November 14, 2025
Update on Scheme and Supreme Court of NSW proceedings
November 10, 2025
MYX Scheme of Arrangement update on FIRB approval
October 30, 2025
Outcome of litigation and update on Scheme
October 15, 2025
MYX announces PBS listing of NEXTSTELLIS in Australia
September 29, 2025
Mayne Pharma addresses recent media articles regarding FIRB
September 7, 2025
2025 Full Year Results Investor Presentation
August 28, 2025
2025 Full Year Results Media Release
August 28, 2025
Full Year Statutory Accounts
August 28, 2025
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
August 15, 2025
Results of Scheme Meeting
June 18, 2025
Chair's address and presentation at the Scheme Meeting
June 17, 2025
Update on litigation with Cosette
June 15, 2025
Supplementary Scheme Booklet
June 4, 2025
Mayne Pharma receives purported notice to terminate SID
June 4, 2025
Update on Scheme of Arrangement with Cosette
June 3, 2025
Response to ASX Aware Letter
May 21, 2025
Update on Scheme with Cosette
May 20, 2025
ASIC registration of Mayne Pharma scheme booklet
May 15, 2025
Court approves convening of scheme meeting
May 15, 2025
Response to ASX Price Query
May 14, 2025
Pause in Trade
May 14, 2025
Response to ASX Query
May 11, 2025
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
April 17, 2025
2025 Half Year Investor Presentation
February 25, 2025
2025 Half Year Media Release
February 25, 2025
Mayne Pharma enters Scheme Implementation Deed with Cosette
February 20, 2025